Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
10,458,130
-
Share change
-
-635,999
-
Total reported value
-
$13,594,000
-
Price per share
-
$1.30
-
Number of holders
-
21
-
Value change
-
-$842,278
-
Number of buys
-
7
-
Number of sells
-
8
Institutional Holders of BIOLINERX LTD - SPONSORED ADR (BLRX) as of Q4 2015
As of 31 Dec 2015,
BIOLINERX LTD - SPONSORED ADR (BLRX) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,458,130 shares.
The largest 10 holders included
Senvest Management, LLC, Broadfin Capital, LLC, ORBIMED ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, Alyeska Investment Group, L.P., Opaleye Management Inc., DEUTSCHE BANK AG\, MENTA CAPITAL LLC, and Benchmark Capital Advisors.
This page lists
21
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.